Wu, Yanyuan <br/><br/>
FOXO1A is a target for HER2-overexpressing breast tumors.  [electronic resource] 

 -  Cancer research  Jul 2010 
 - 5475-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-10-0176  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Chromones--pharmacology<br/>Down-Regulation<br/>Drug Synergism<br/>Enzyme Activation<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Forkhead Box Protein O1<br/>Forkhead Transcription Factors--biosynthesis<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Morpholines--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>RNA, Messenger--biosynthesis<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Transfection<br/>Trastuzumab